PURPOSE: Vascular dropout and angiogenesis are hallmarks of the progression of diabetic retinopathy (DR). However, current evaluation of DR relies on grading of secondary vascular effects, such as microaneurysms and hemorrhages, by clinical examination instead of by evaluation of actual vascular changes. The purpose of this study was to map and quantify vascular changes during progression of DR by VESsel GENeration Analysis (VESGEN). METHODS: In this prospective cross-sectional study, 15 eyes with DR were evaluated with fluorescein angiography (FA) and color fundus photography, and were graded using modified Early Treatment Diabetic Retinopathy Study criteria. FA images were separated by semiautomatic image processing into arterial and venous trees. Vessel length density (L(v)), number density (N(v)), and diameter (D(v)) were analyzed in a masked fashion with VESGEN software. Each vascular tree was automatically segmented into branching generations (G(1)...G(8) or G(9)) by vessel diameter and branching. Vascular remodeling status (VRS) for N(v) and L(v) was graded 1 to 4 for increasing severity of vascular change. RESULTS: By N(v) and L(v), VRS correlated significantly with the independent clinical diagnosis of mild to proliferative DR (13/15 eyes). N(v) and L(v) of smaller vessels (G(> or =6)) increased from VRS1 to VRS2 by 2.4 x and 1.6 x, decreased from VRS2 to VRS3 by 0.4 x and 0.6 x, and increased from VRS3 to VRS4 by 1.7 x and 1.5 x (P < 0.01). Throughout DR progression, the density of larger vessels (G(1-5)) remained essentially unchanged, and D(v1-5) increased slightly. CONCLUSIONS: Vessel density oscillated with the progression of DR. Alternating phases of angiogenesis/neovascularization and vascular dropout were dominated first by remodeling of arteries and subsequently by veins.
PURPOSE: Vascular dropout and angiogenesis are hallmarks of the progression of diabetic retinopathy (DR). However, current evaluation of DR relies on grading of secondary vascular effects, such as microaneurysms and hemorrhages, by clinical examination instead of by evaluation of actual vascular changes. The purpose of this study was to map and quantify vascular changes during progression of DR by VESsel GENeration Analysis (VESGEN). METHODS: In this prospective cross-sectional study, 15 eyes with DR were evaluated with fluorescein angiography (FA) and color fundus photography, and were graded using modified Early Treatment Diabetic Retinopathy Study criteria. FA images were separated by semiautomatic image processing into arterial and venous trees. Vessel length density (L(v)), number density (N(v)), and diameter (D(v)) were analyzed in a masked fashion with VESGEN software. Each vascular tree was automatically segmented into branching generations (G(1)...G(8) or G(9)) by vessel diameter and branching. Vascular remodeling status (VRS) for N(v) and L(v) was graded 1 to 4 for increasing severity of vascular change. RESULTS: By N(v) and L(v), VRS correlated significantly with the independent clinical diagnosis of mild to proliferative DR (13/15 eyes). N(v) and L(v) of smaller vessels (G(> or =6)) increased from VRS1 to VRS2 by 2.4 x and 1.6 x, decreased from VRS2 to VRS3 by 0.4 x and 0.6 x, and increased from VRS3 to VRS4 by 1.7 x and 1.5 x (P < 0.01). Throughout DR progression, the density of larger vessels (G(1-5)) remained essentially unchanged, and D(v1-5) increased slightly. CONCLUSIONS: Vessel density oscillated with the progression of DR. Alternating phases of angiogenesis/neovascularization and vascular dropout were dominated first by remodeling of arteries and subsequently by veins.
Authors: Arpenik Avakian; Robert E Kalina; E Helene Sage; Avni H Rambhia; Katherine E Elliott; Elaine L Chuang; John I Clark; Jenq-Neng Hwang; Patricia Parsons-Wingerter Journal: Curr Eye Res Date: 2002-04 Impact factor: 2.424
Authors: Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz Journal: J Cell Biol Date: 2003-06-16 Impact factor: 10.539
Authors: Ştefan Ţălu; Sebastian Stach; Dan Mihai Călugăru; Carmen Alina Lupaşcu; Simona Delia Nicoară Journal: Int J Ophthalmol Date: 2017-03-18 Impact factor: 1.779
Authors: Carol Yim-lui Cheung; Ecosse Lamoureux; M Kamran Ikram; M Bayu Sasongko; Jie Ding; Yingfeng Zheng; Paul Mitchell; Jie Jin Wang; Tien Yin Wong Journal: J Diabetes Sci Technol Date: 2012-05-01
Authors: Alice Y Kim; Zhongdi Chu; Anoush Shahidzadeh; Ruikang K Wang; Carmen A Puliafito; Amir H Kashani Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799
Authors: Ruchi J Vyas; Millennia Young; Matthew C Murray; Marina Predovic; Shiyin Lim; Nicole M Jacobs; Sara S Mason; Susana B Zanello; Giovanni Taibbi; Gianmarco Vizzeri; Patricia Parsons-Wingerter Journal: Invest Ophthalmol Vis Sci Date: 2020-12-01 Impact factor: 4.799
Authors: Chang-Hyun Gil; Dibyendu Chakraborty; Cristiano P Vieira; Nutan Prasain; Sergio Li Calzi; Seth D Fortmann; Ping Hu; Kimihiko Banno; Mohamed Jamal; Chao Huang; Micheli S Sielski; Yang Lin; Xinxin Huang; Mariana D Dupont; Jason L Floyd; Ram Prasad; Ana Leda F Longhini; Trevor J McGill; Hyung-Min Chung; Michael P Murphy; Darrell N Kotton; Michael E Boulton; Mervin C Yoder; Maria B Grant Journal: Sci Adv Date: 2022-03-04 Impact factor: 14.957